Fig. 5: Overview of oligosaccharide products and deprotection conditions.

a HMOs deprotection conditions; b Collection of neutral linear, symmetrical- and unsymmetrical-branched LacNAc-based oligosaccharides and HMOs.

a HMOs deprotection conditions; b Collection of neutral linear, symmetrical- and unsymmetrical-branched LacNAc-based oligosaccharides and HMOs.